Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Antimicrobial Therapeutics Companies

ID: MRFR/HC/10234-HCR
128 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Antimicrobial therapeutics encompass a broad category of drugs designed to combat microbial infections, including bacteria, viruses, fungi, and parasites. These drugs are crucial for treating various infectious diseases.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Antimicrobial Therapeutics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.3%
2024 Market Size$ 111.63 Billion
2025 Market Size$ 117.55 Billion
2035 Market Size$ 197.05 Billion
Key Players
Pfizer Inc
Merck & Co Inc
Johnson & Johnson
Novartis AG
Bayer AG
GlaxoSmithKline plc
Opportunities
  • Advancements in Biotechnology
  • Regulatory Support and Initiatives
  • Growing Incidence of Infectious Diseases

Top Industry Leaders in the Antimicrobial Therapeutics Market

Antimicrobial Therapeutics Key Companies
 
Latest Antimicrobial Therapeutics Companies Update:

Entasis Therapeutics Announced positive Phase 3 trial results for ecneplanin, a broad-spectrum antibiotic targeting Gram-negative bacteria, showcasing potential for treating multidrug-resistant infections.

Spero Therapeutics Received FDA Fast Track designation for teixobactin, a first-in-class antibiotic with a unique mechanism of action, aiming to address life-threatening infections caused by highly resistant bacteria.

Microbiotica Ltd Launched their Live Biotherapeutic Product (LBP) platform, utilizing naturally occurring gut bacteria to restore microbial balance and combat antimicrobial resistance.

Cellectis S.A Developed phage-based therapies targeting specific bacterial strains, offering a promising alternative approach to traditional antibiotics.

Cidara Therapeutics Received FDA Breakthrough Therapy designation for CIDARA677e, a next-generation antibiotic effective against multidrug-resistant Gram-negative pathogens.

List of Antimicrobial Therapeutics Key companies in the market
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bavarian Nordic AS
  • Biocidium Biopharmaceuticals Inc.
  • Bristol Myers Squibb Co.
  • Cadila Pharmaceuticals Ltd.
  • CSL Ltd.
  • Emergent BioSolutions Inc.
  • Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Novartis AG
  • Novavax Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Wockhardt Ltd.